Mitotane (2,4′-DDD), Antineoplastic Agent

Mitotane (2,4′-DDD), an isomer of DDD and derivative of dichlorodiphenyltrichloroethane (DDT), is an antineoplastic agent, can be used to research adrenocortical carcinoma. Mitotane exert its adrenocorticolytic effect at least in part through lipotoxicity induced by intracellular free cholesterol (FC) accumulation. Mitotane can have direct pituitary effects on corticotroph cells. Mitotane can induce CYP3A4 gene expression via steroid and xenobiotic receptor (SXR) activation, and has agent-agent interactions. - Mechanism of Action & Protocol.

Mitotane (Lsodren), CAS:53-19-0, Antineoplastic agents against adrenocortical carcinoma, High Purity

antineoplastic MedChemExpress (MCE) Life Science Reagents

Adrenocortical carcinoma: a clinician's update

Mitotane Lipid Nanocarriers and Enantiomers

Mitotane 500mg Tablets (Lysodren), Bristol-Myers at Rs 68000/bottle in Raipur

Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro

Mitotane - wikidoc

Mitotane Lipid Nanocarriers and Enantiomers

Mitotane, C14H10Cl4

Frontiers The Effects of Cumulative Dose and Polymorphisms in CYP2B6 on the Mitotane Plasma Trough Concentrations in Chinese Patients With Advanced Adrenocortical Carcinoma